Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

9.860 -0.150 (-1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250,793
Open 9.980
Bid (Size) 9.850 (4)
Ask (Size) 9.880 (3)
Prev. Close 10.01
Today's Range 9.800 - 10.12
52wk Range 5.450 - 18.98
Shares Outstanding 24,296,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroPace to Participate in Upcoming Healthcare Conferences
From NeuroPace, Inc.
Via Business Wire
NeuroPace Revenue Jumps 22 Percent in Q2
Via The Motley Fool

Performance

YTD
-14.9%
-14.9%
1 Month
+9.2%
+9.2%
3 Month
-11.1%
-11.1%
6 Month
-12.3%
-12.3%
1 Year
+32.7%
+32.7%

More News

Read More
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
NeuroPace Reports Record Q2 Revenue
Via The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
Analyst Expectations For NeuroPace's Future
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
From Pomerantz LLP
Via GlobeNewswire
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga

Frequently Asked Questions

Is Neuropace, Inc. - Common Stock publicly traded?
Yes, Neuropace, Inc. - Common Stock is publicly traded.
What exchange does Neuropace, Inc. - Common Stock trade on?
Neuropace, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuropace, Inc. - Common Stock?
The ticker symbol for Neuropace, Inc. - Common Stock is NPCE on the Nasdaq Stock Market
What is the current price of Neuropace, Inc. - Common Stock?
The current price of Neuropace, Inc. - Common Stock is 9.860
When was Neuropace, Inc. - Common Stock last traded?
The last trade of Neuropace, Inc. - Common Stock was at 09/12/25 04:00 PM ET
What is the market capitalization of Neuropace, Inc. - Common Stock?
The market capitalization of Neuropace, Inc. - Common Stock is 239.56M
How many shares of Neuropace, Inc. - Common Stock are outstanding?
Neuropace, Inc. - Common Stock has 240M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.